Back to News
Market Impact: 0.25
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
Source: 247wallst.com
Healthcare & BiotechMarket Technicals & Flows
Moderna shares rose 8% to $147.37 in Friday morning trading, significantly outperforming a quiet biotech sector and only modest gains in broader U.S. equities. The article identifies a notable single-stock rally but provides no catalyst, earnings update, or guidance change.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
MRNA0.45
More News
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
- Stocks making the biggest moves premarket: Verizon, Tesla, Moderna & more
- Stocks making the biggest moves midday: Lockheed Martin, JetBlue, CoreWeave, Surgery Partners & more
- Lula wins Brazil runoff after prediction markets favored Bolsonaro
- Brazil’s real sinks after Lula’s re-election victory